PTGS2 and neoplasm: We have reported recently that human α3(IV)NC1 binds to α3β1/αVβ3 integrins and inhibits hypoxic cyclo-oxygenase-2 (COX-2) signaling leading to inhibition of tumor angiogenesis and tumor growth in mice (Boosani et al. 2007).